Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2172 (107th)

Cloning Prohibition Act of 2001

referredUnited States· United States Congress· EN

Introduced

14 June 2001

Last action

25 June 2001 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Greenwood, James C. [R-PA-8], Rep. Wolf, Frank R. [R-VA-10], Rep. Owens, Major R. [D-NY-11], Rep. Neal, Richard E. [D-MA-1], Rep. Pallone, Frank [D-NJ-6], Rep. McCarthy, Carolyn [D-NY-4], Rep. Deutsch, Peter [D-FL-20], Rep. Gillmor, Paul E. [R-OH-5], Rep. DeGette, Diana [D-CO-1], Rep. Dreier, David [R-CA-26], Rep. Stark, Fortney Pete [D-CA-13], Rep. Eshoo, Anna G. [D-CA-18], Rep. Towns, Edolphus [D-NY-10], Rep. Langevin, James R. [D-RI-2], Rep. Wu, David [D-OR-1], Rep. Waxman, Henry A. [D-CA-33], Rep. Strickland, Ted [D-OH-6]

Subjects

Healthcare

Source updated

19 August 2025

Healthcare

Summary

Cloning Prohibition Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit any person from: (1) using or attempting to use human somatic cell nuclear transfer technology with the intent to initiate a pregnancy; or (2) shipping or transporting the cellular product resulting from such technology knowing that it is intended for such use. Sets forth registration requirements for individuals who intend to perform human somatic cell nuclear transfer technology, including attesting that such prohibitions will not be violated. Directs the Secretary of Health and Human Services to request the Institute of Medicine to enter into an agreement to conduct a study to: (1) review the current state of knowledge about the biological properties of stem cells obtained from embryos and fetal and adult tissues; (2) evaluate the current state of knowledge about biological differences among stem cells obtained from embryos and fetal and adult tissues and the consequences for research and medicine; and (3) assess what is currently known about the ability of stem cells to generate neurons, heart, kidney, blood, liver, and other tissues and the potential clinical uses of these tissues.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 June 2001

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 14 June 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 14 June 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 25 June 2001

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 14 June 2001

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 14 June 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 14 June 2001

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.